Of note, the absence of CD4+ T cells in control non-IPA treated mice reduced the metastatic burden compared to IPA-treated mice (Fig. 5m, n), likely due to the depletion of regulatory CD4+ T cells in control mice. This evidence concerns the gene CD4 and Ito hypomelanosis.